Likewise, the increase in volume in operations with primary epilepsy codes in 2020 could be related to increased adoption of DBS procedures for this indication following the 2018 FDA clearance of DBS devices for patients with focal epilepsy who have not achieved seizure control after trying three or more epilepsy medications; future years of NIS data may help clarify if this is indeed an increasing trend.
← all excerpts
Changes in deep brain stimulation surgeries between 2019 and 2020: A national inpatient sample analysis.
1
—
—